4.7 Editorial Material

Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan A Retrospective Observational Study

Yingzhen Du et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

News Item Medicine, General & Internal

Covid-19: WHO declares pandemic because of alarming levels of spread, severity, and inaction

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Immunology

DAMPs from cell death to new life

Emilie Venereau et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury

Maria Entezari et al.

REDOX BIOLOGY (2014)

Article Medicine, Research & Experimental

Alarmins: awaiting a clinical response

James K. Chan et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Oncology

Immunogenic cell death and DAMPs in cancer therapy

Dmitri V. Krysko et al.

NATURE REVIEWS CANCER (2012)